SAJA Pharmaceuticals; is pleased to sign a memorandum of understanding (MOU) and strategic partnership agreement with Emirates Society of Internal Medicine (ESIM) in Dubai
Dubai UAE
Sallam Sallam
Upon this alliance and partnership, SAJA will work with ESIN in the key areas of specialty learning, facilitating initiatives to improve practice, promoting the latest updates and best practices in the field of internal medicine.
ESIM activities in UAE is providing key learnings to the community to help them stay connected with the latest updates in the field of Internal Medicine, supporting research, sharing the key insights into career enhancement, supporting with training blueprints, speakers, and logistics, and providing CME for the training courses to the health care professionals in UAE and Gulf region.
The agreement was signed in the presence Dr. Mahmoud Ghaly, General Manager of SAJA Pharmaceuticals Company, and Doctor Jamila M. Ali Bin Adi, President of Emirates Society of Internal Medicine.
This to complement the company’s leading role in the field of Cardiovascular medicines, which allows providing health care professionals with products of high quality and efficiency to improve the quality of life of the patient and the community, based on the company’s vision of its role and commitment towards community and the health care sector.
This resulted in the presence of SAJA company at the forefront of pharmaceutical companies in the country
